Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Oxitan 50 mg Injection
Manufacturer/Marketed By : Fresenius Kabi India Pvt Ltd
$28.74 $16.21
Sidmex Inovia offers bulk export supply of Oxitan 50 mg Injection (Oxaliplatin 50 mg) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.Documents, cold-chain...
Oxaliplatin 50 mg
Active Pharmaceutical Ingredient
Oxitan 50 mg Injection
$28.74
$16.21
Sidmex Inovia offers bulk export supply of Oxitan 50 mg Injection (Oxaliplatin 50 mg) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.
Documents, cold-chain shipping and tenders: see our Export FAQ.
Priority markets: United Arab Emirates, Brazil, Turkey, Singapore, Kenya, Somalia, Ghana, Saudi Arabia, Mauritius, Nigeria, Tanzania, Senegal, Democratic Republic of the Congo, Mali. We also export worldwide, including:
Middle East: Oman, Qatar, Kuwait, Bahrain, Iraq, Jordan, Lebanon, Yemen, Iran
Africa: Egypt, Algeria, Morocco, Libya, Burkina Faso, Côte d'Ivoire, Gambia, Rwanda, Ethiopia, Djibouti, South Africa, Zimbabwe
Asia: Sri Lanka, Bangladesh, Nepal, Maldives, Philippines, Vietnam, Laos, Malaysia, Thailand, Taiwan
CIS & Eastern Europe: Russia, Kazakhstan, Uzbekistan, Azerbaijan, Georgia, Serbia, Latvia, Tajikistan
Latin America & Caribbean: Mexico, Chile, Peru, Colombia, Bolivia, Venezuela
Europe & Other: Switzerland, United Kingdom, Canada
Related products we supply: Oxitan 100 mg Injection
Oxitan 50 mg Injection is a vital treatment option for patients battling colon and rectal cancer, as it effectively disrupts the proliferation of cancer cells. This medication works by inhibiting DNA synthesis within the cancerous cells, thereby slowing tumor growth and aiding in the management of this aggressive disease. It is essential to use Oxitan under the supervision of a qualified healthcare professional, as it may cause side effects such as nausea, fatigue, and potential allergic reactions. Patients should be aware of important warnings, including the risk of severe infections and liver toxicity, which necessitate regular monitoring during treatment. For optimal results, Oxitan is typically administered in conjunction with other chemotherapy agents, enhancing its effectiveness. Individuals with pre-existing liver conditions or those who are pregnant should exercise caution and discuss their health history with their doctor before starting this injection. With its targeted approach, Oxitan 50 mg Injection stands as a crucial component in the fight against colon and rectal cancer, offering hope to patients and their families. Always consult your healthcare provider to ensure this treatment aligns with your specific medical needs and conditions.
Active Pharmaceutical Ingredient
Uses
• Oxitan 50 mg injection is primarily used in the treatment of advanced colorectal cancer. This medication works by inhibiting cancer cell growth and proliferation, helping to manage the progression of the disease. It is often administered in combination with other chemotherapy agents to enhance treatment efficacy. Patients typically receive this injection under the supervision of healthcare professionals to ensure proper administration.
• In addition to colorectal cancer, Oxitan 50 mg injection may also be utilized for certain types of ovarian cancer. The drug's mechanism of action targets rapidly dividing cancer cells, which can contribute to tumor reduction. This treatment option is often explored when other therapies have been exhausted or are not suitable for the patient. Regular monitoring is essential during treatment to assess the drug's effectiveness.
• Healthcare providers may recommend Oxitan 50 mg injection for patients who have undergone surgical procedures for cancer removal. The injection can help in preventing cancer recurrence by eliminating residual cancer cells. This proactive approach is crucial in enhancing long-term patient outcomes. Administration of this medication is always carried out in a controlled medical environment to ensure patient safety.
• Oxitan 50 mg injection is also considered for use in clinical trials aimed at exploring its effectiveness in other malignancies. Researchers are continuously studying its potential benefits in various cancer types, contributing to the advancement of oncology treatments. Participation in such trials may provide patients with access to cutting-edge therapies. As always, treatment decisions involving Oxitan 50 mg injection are made collaboratively between patients and their healthcare teams.
Benefits
In cancer of the colon and rectum: Colorectal cancer, also known as colorectal cancer (CRC) or bowel cancer, is the development of cancer in two parts of the large intestine: the colon or rectum. Symptoms of this type of cancer may include bloody stools, changes in bowel movements, weight loss, and tiredness. Oxitan 50 mg Injection also treats and reduces the risk of other cancerous growths (polyps) and colorectal cancer. It works by killing or stopping the growth of cancer cells and preventing them from multiplying. It is an effective but highly toxic medicine, and you should discuss the risks and benefits with your doctor. While you are receiving this treatment, you should avoid drinking alcohol or smoking and drink plenty of water to stay hydrated.
Side Effects
Oxitan 50 mg Injection may cause some adverse effects, which may vary from person to person. Some of the adverse effects are
Most Common Side Effects
• Decrease in number of blood cells
• Unpleasant sensation in the throat
• Indigestion and heartburn
• Blood in urine
• Blood clots
• High BP
• Depression and insomnia
• Low levels of calcium in the blood
• Fatigue
• Decrease in white blood cells
Common Side Effects
• Abnormal bleeding or bruising
• Severe allergic reactions
• Vomiting
• Diarrhea
• Sore throat and fever
• Irregular heartbeat
• Muscle pain and weakness
• Extreme tiredness and breathlessness
• Headache
• Blurred vision
• Seizures
How To Use
Oxitan 50 mg Injection is injected into the patient's body under the supervision of the doctor or the nurse. Do not self-administer the medicine.
Safety Advice
• Alcohol: The safety of drinking alcohol while taking Oxitan 50 mg is not known. It's best to ask your doctor for advice.
• Kidney: Oxitan 50 mg Injection should be used carefully in patients with severe kidney disease, and a dose adjustment might be necessary. It's important to consult your doctor for guidance. There is limited information on using Oxitan 50 Injection in patients with severe kidney problems. However, no dose adjustment is needed for patients with mild to moderate kidney disease.
• Breastfeeding: Using Oxitan 50 Injection while breastfeeding is not safe. Research indicates that it could be harmful to the baby.
• Liver: Patients with liver disease should use Oxitan 50 mg Injection carefully. You may need a dosage adjustment, so be sure to talk to your doctor.
• Pregnancy: Oxitan 50 mg Injection is not safe to use during pregnancy because it poses clear risks to the unborn baby. However, a doctor might still prescribe it in rare and serious cases if the benefits outweigh the risks. Always seek advice from your health practitioner.
• Driving: Oxitan 50 mg Injection can lead to side effects that might impair your driving ability. Treatment with Oxitan 50 mg could increase the chances of experiencing dizziness, nausea, vomiting, and other neurological issues that impact your ability to walk, which can also affect your capacity to drive safely.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.